Abstract
The best treatment for prostate cancer is an individualized choice specific to each patient. The decision to undergo prostate cancer surgery is based on several factors including the patient’s preoperative health status, ability to gain oncologic control, and the patient’s previous surgical history. When considering a patient for radical prostatectomy (RP), previous prostate surgery must be considered. Reoperative surgery for prostate cancer can be associated with technical challenges that may impact the long-term functional and oncologic outcomes. Previous prostate procedures can vary from treatment of benign prostatic hyperplasia (BPH) to primary local therapy for prostate cancer. Thus, one must be aware of the added challenges and risks that such surgical history portends and relate this information to the patient prior to radical prostatectomy. In this chapter, we seek to outline how previous prostate surgery impacts the technical aspects and outcomes of both primary and salvage radical prostatectomy in patients with adenocarcinoma of the prostate.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Bandhauer K, Senn E. Radical retropubic prostatectomy after transurethral prostate resection. Eur Urol. 1988;15:180–181.
Lindner A, DeKernion JB, Smith RB, et al. Risk of urinary incontinence following radical prostatectomy. J Urol. 1983;129:1007–1008.
Elder JS, Gibbons RP, Correa RJ, et al. Morbidity of radical perineal prostatectomy following transurethral resection of the prostate. J Urol. 1984; 132: 55–57.
Eastham JA, Kattan MW, Rogers E, et al. Risk factors for urinary incontinence after radical prostatectomy. J Urol. 1996;156(5):1707–1713.
Colombo R, Naspro R, Salonia A, et al. Radical prostatectomy after previous prostate surgery: clinical and functional outcomes. J Urol. 2006;176:2459–2463.
Katz R, Borkowski T, Hoznek A et al. Laparoscopic radical prostatectomy in patients following transurethral resection of the prostate. Urol Int. 2006;77:216–221.
Stolzenberg J, Kossen MT, Minh D, et al. Impact of previous surgery on endoscopic extraperitoneal radical prostatectomy. Urology. 2005;65:325–331.
Borboroglu PG, Sands JP, Roberts JL, et al. Risk factors for vesicourethral anastomotic stricture after radical prostatectomy. Urology. 2000;56:96–100.
Catalona WJ, Carvhalhal GF, Mager DE, Smith DS. Potency, continence, and complication rates in 1,870 consecutive radical retropubic prostatectomies. J Urol. 1999;162: 433–438.
Menard Y, Guillaume G, Hoznek A, et al. Comparison of laparoscopic radical prostatectomy with and without previous transurethral prostate resection. J Urol. 2006;175:368A.
Sacco E, Prayer-Galetti T, Pinto F, et al. Urinary incontinence after radical prostatectomy: incidence by definition, risk factors and temporal trend in a large series with long-term follow-up. BJU. 2006; 97:1234–1241.
Eden CG, Richards AJ, Ooi J, et al. Previous bladder outlet surgery does not affect medium-term outcomes after laparoscopic radical prostatectomy. BJU. 2006;99:399–402.
Guilloneau B, El-Fettouh H, Baumert H, et al. Laparoscopic radical prostatectomy: oncological evaluation after 1,000 cases at Montsouris institute. J Urol. 2003;169:1261–1266.
Walsh PC. Radical prostatectomy for the treatment of localized prostatic carcinoma. Urol Clin North Am. 1982;7:583.
Goodwin WE. Radical prostatectomy after previous prostatic surgery: technical problems encountered in treatment of occult carcinoma. JAMA. 1952;148:799.
Ramon J, Rossignol G, Leandri P, et al. Morbidity of radical retropubic prostatectomy following previous prostate resection. J Surg Oncol. 1994;55:9–14.
Roehl KA, Han M, Ramos CG, et al. Cancer progression and survival rates following anatomical radical prostatectomy in 3.478 consecutive patients: long-term results. J Urol. 2004;172:910–914.
Hull GW, Rabbani F, Scardino PT, et al. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol. 2002;167:528–534.
Blute ML, Bostwick DG, Bergstrath EJ, et al. Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy. Urology. 1997;50:733–739.
Katz R, Salomon L, Hoznek A, et al. Positive surgical margins in laparoscopic radical prostatectomy: the impact of apical dissection, bladder, neck remodeling, and nerve preservation. J Urol. 2003;169:2049–2052.
Iselin CE, Robertson JE, Paulson DF. Radical perineal prostatectomy: oncological outcome during a 20-year period. J Urol. 1999;161:163–168.
Stolzenburg JW, Rabenault R, Do M, et al. Endoscopic extraperitoneal radical prostatectomy: the University of Leipzig experience of 1,300 cases. World J Urol. 2007;25:45–51.
Secin FP, Serio A, Bianco FJ, et al. Preoperative and intraoperative risk factors for side-specific positive surgical margins in laparoscopic radical prostatectomy. Eur Urol. 2007;51:764–771.
Suruya BV, Provet J, Johanson KE, et al. Anastomotic strictures following radical prostatectomy: risk factors and management. J Urol. 1990;143:755–758.
Tomschi W, Suster G, Holtl W. Bladder neck strictures after radical retropubic prostatectomy: still an unsolved problem. BJU. 1998;81:823–826.
Kostakopoulos A, Argiropoulos V, Protogerou V, et al. Vesicourethral anastomotic strictures after radical retropubic prostatectomy: the experience of a single institution. Urol Int. 2004;72:17–20.
Park R, Martin S, Goldberg JD, et al. Anastomotic strictures following radical prostatectomy: insights into incidence, effectiveness of intervention, effect on continence, and factors predisposing to occurrence. Urology. 2001;57:742–746.
Steiner MS, Morton RA, Walsh PC. Impact of anatomical radical retropubic prostatectomy on urinary continence. J Urol. 1991;145:512–515.
Eastham JA, Scardino PT. Radical prostatectomy. In: Walsh PC, Retik AB, Vaughn ED, et al., eds. Campbell’s Urology. Philadelphia: Saunders, Elsevier Science; 2002:3080–3102.
Walsh PC, Donker PJ. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol. 1982;128:492–7.
Cappelleri JC, Rosen RC, Smith MD, et al. Diagnostic evaluation of the erectile function domain of the international index of erectile function. Urology. 1999;54:346–351.
Rosen RC, Cappelleri JC, Gendrano N. The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res. 2002;14:226–244.
Rosen RC, Riley A, Wagner G, et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822–830.
Nichols RT, Barry MJ, Hodges CV. The morbidity of radical prostatectomy for multifocal stage I prostatic adenocarcinoma. J Urol. 1977;117:83.
Bass RB and Barrett DM. Radical retropubic prostatectomy after transurethral prostatic resection. J Urol. 1980;124:495.
Stephenson AJ, Eastham JA. Role of salvage radical prostatectomy for recurrent prostate cancer after radiation therapy. J Clin Oncol. 2005;23:8198–8203.
Stephenson AJ, Shariat SF, Zelefsky MJ, et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA. 2004;291:1325–1332.
Bianco FJ, PT Scardino, Stephenson AJ, et al. Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Int J Radiat Oncol Biol Phys. 2005;62:448–453.
Gheiler EL, Tefilli MV, Tiguert R, et al. Predictors for maximal outcome in patients undergoing salvage surgery for radio-recurrent prostate cancer. Urology. 1998;51:789–795.
Amling CL, Lerner SE, Martin SK, et al. Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer. J Urol. 1999;161:857–863.
Ward JF, Sebo TJ, Blute ML, et al. Salvage surgery for radiorecurrent prostate cancer: contemporary outcomes. J Urol. 2005;173:1156–1160.
Sanderson KM, Penson DF, Cai J, et al. Salvage radical prostatectomy: Quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer. J Urol. 2006;176:2025–2032.
Zagars GK, Pollack A, von Eschenbach AC. Prostate cancer and radiation therapy: the message conveyed by serum prostate-specific antigen. Int J Radiat Oncol Biol Phys. 1995;33:23–35.
Schellhammer PF, Kuban DA, El-Mahdi AM. Treatment of clinical local failure after radiation therapy for prostate carcinoma. J Urol. 1993;150:1851–1855.
Consensus statement: guidelines for PSA following radiation therapy. ASTRO Consensus Panel. Int J Radiat Oncol Biol Phys. 1997;37:1035–1041.
Hanlon AL, Pinover WH, Horwitz EM, et al. Patterns and fate of PSA bouncing following 3D-CRT. Int J Radiat Oncol Biol Phys. 2001;50:845–849.
Rosser CJ, Kuban DA, Levy LB et al. Prostate specific antigen bounce phenomenon after external beam radiation for clinically localized prostate cancer. J Urol. 2002; 168:2001–2005.
Critz FA, Williams WH, Benton JB et al. Prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancer. J Urol. 2000;163:1085–1089.
Ray ME, Thames HD, Levy LB, et al. PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis. Int J Radiat Oncol Biol Phys. 2006;64:1140–1150.
Crook JM, Perry GA, Robertson S, et al. Routine prostate biopsies following radiotherapy for prostate cancer: results for 226 patients. Urology. 1995;45:624–631.
Scardino PT. The prognostic significance of biopsies after radiotherapy for prostatic cancer. Semin Urol. 1985;1:243–251.
Crook J, Malone S, Perry G, et al. Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients. Int J Radiat Oncol Biol Phys. 2000;48:355–367.
Eastham JA, Scardino PT. Salvage radical prostatectomy for recurrence of prostate cancer after radiation. In: Vogelzang NJ, Scardino PT, Shipley WU, et al., eds. Genioturinary Oncology. Philadelphia: Lippincott Williams & Wilkins; 2006:306–314.
Borland RN, Walsh PC. The management of rectal injury during radical retropubic prostatectomy. J Urol. 1992;147:905–907.
Guillonneau B, Gupta R, El Fettouh H, et al. Laparoscopic management of rectal injury during laparoscopic radical prostatectomy. J Urol. 2003;169:1694–1696.
Katz R, Borkowski T, Hoznek A, et al. Operative management of rectal injuries during laparoscopic radical prostatectomy. Urology. 2003;62:310–313.
Harpester LE, Rommel FM, Seiber PR, et al. Incidence and management of rectal injury associated with radical prostatectomy in a community based urology practice. J Urol. 1995;154:1435–1438.
Smith AM, Veenema RJ.Management of rectal injury and rectourethral fistulas following radical retropubic prostatectomy. J Urol. 1972;108:778–789.
Dillioglugil O, Leibman BD, Leibman NS, et al. Risk factors for complication and morbidity after radical retropubic prostatectomy. J Urol. 1997;157:1760–1767.
Stephenson AJ, Scardino PT, Bianco FJ, et al. Morbidity and functional outcomes after salvagae radical prostatectomy for locally recurrent prostate cancer after radiation therapy. J Urol 2004; 172: 2239–2243.
Garzotto M, Wajsman Z. Androgen deprivation with salvage surgery for radiorecurrent prostate cancer: Results at 5-year follow-up. J Urol. 1998;159:950–955.
Cheng L, Sebo TJ, Slezak J, et al. Predictors of survival for prostate carcinoma patients treated with salvage radical prostatectomy after radiation therapy. Cancer. 1998;83:2164–2171.
Han M, Partin AW, Chan DY, et al. An evaluation of the decreasing incidence of positive surgical margins in a large retropubic prostatectomy series. J Urol. 2004;171:23–26.
Wei JT, Dunn RL, Litwin MS, et al. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000;56:899–905.
Masterson TA, Stephenson AJ, Scardino PT, et al. Recovery of erectile function after salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Urology. 2005;66:623–626.
Russo PM. Salvage radical prostatectomy after radiation therapy and brachytherapy. J Endourol. 2000;14:385–390.
Chen BT, Wood DP. Salvage prostatectomy in patients who have failed radiation therapy or cryotherapy as primary treatment for prostate cancer. Urology. 2003;62:69–78.
Pisters LL, English SF, Scott SM, et al. Salvage prostatectomy with continent catheterizable urinary reconstruction: A novel approach to recurrent prostate cancer after radiation therapy. J Urol. 2000;163:1771–1774.
Vallancein R, Gupta R, Cathelineau X, et al. Initial results of salvage laparoscopic radical prostatectomy after radiation failure. J Urol. 2003;170:1838–1840.
Amling CL, Blute ML, Bergstralh EJ, et al. Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years. J Urol. 2000;164:101–105.
Han M, Partin AW, Zahurak M, et al. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol. 2000;169:517–23.
Cadeddu JA, Partin AW, De Weese TL, et al. Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy. J Urol. 1998;159:173–177.
Leibovici D, Pagliaro L, Rosser CJ, et al. Salvage surgery for bulky local recurrence of prostate cancer following radical prostatectomy. J Urol. 2005;173:781–783.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Amling, C., Clayton, D. (2009). Reoperative Surgery for Prostate Cancer. In: Billingham, R., Kobashi, K., Peters, W. (eds) Reoperative Pelvic Surgery. Springer, New York, NY. https://doi.org/10.1007/b14187_9
Download citation
DOI: https://doi.org/10.1007/b14187_9
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-89998-5
Online ISBN: 978-0-387-89999-2
eBook Packages: MedicineMedicine (R0)